Kolade Muchaili Agboola, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Flutter | 1 | 2021 | 263 | 0.680 |
Why?
|
Catheter Ablation | 5 | 2023 | 2758 | 0.650 |
Why?
|
Foramen Ovale, Patent | 1 | 2019 | 223 | 0.540 |
Why?
|
Pacemaker, Artificial | 1 | 2019 | 816 | 0.440 |
Why?
|
Hedgehog Proteins | 6 | 2012 | 783 | 0.390 |
Why?
|
Atrial Fibrillation | 4 | 2023 | 5035 | 0.390 |
Why?
|
Defibrillators, Implantable | 1 | 2019 | 1440 | 0.340 |
Why?
|
Brain Ischemia | 1 | 2019 | 3265 | 0.250 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2021 | 119 | 0.190 |
Why?
|
Ablation Techniques | 1 | 2023 | 249 | 0.180 |
Why?
|
Hepatic Stellate Cells | 5 | 2012 | 109 | 0.180 |
Why?
|
Osteopontin | 2 | 2012 | 294 | 0.170 |
Why?
|
Liver Cirrhosis | 4 | 2010 | 1862 | 0.170 |
Why?
|
Sarcoidosis | 1 | 2023 | 506 | 0.150 |
Why?
|
Natural Killer T-Cells | 2 | 2012 | 316 | 0.150 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 850 | 0.140 |
Why?
|
Fatty Liver | 3 | 2012 | 727 | 0.140 |
Why?
|
Steroids | 1 | 2021 | 930 | 0.140 |
Why?
|
Stroke | 1 | 2019 | 9981 | 0.140 |
Why?
|
Myocarditis | 1 | 2023 | 771 | 0.130 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2023 | 1265 | 0.120 |
Why?
|
Tachycardia, Ventricular | 1 | 2023 | 1273 | 0.120 |
Why?
|
Cardiomyopathies | 1 | 2023 | 1912 | 0.100 |
Why?
|
Catheters | 2 | 2023 | 425 | 0.090 |
Why?
|
Myofibroblasts | 1 | 2010 | 222 | 0.080 |
Why?
|
Cell-Derived Microparticles | 1 | 2008 | 168 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9145 | 0.070 |
Why?
|
Echocardiography | 1 | 2019 | 5099 | 0.070 |
Why?
|
Hepatocytes | 2 | 2010 | 1211 | 0.060 |
Why?
|
Signal Transduction | 5 | 2012 | 23406 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2023 | 63115 | 0.060 |
Why?
|
Registries | 1 | 2019 | 8091 | 0.060 |
Why?
|
Viral Proteins | 1 | 2010 | 1900 | 0.050 |
Why?
|
Leptin | 1 | 2010 | 1600 | 0.050 |
Why?
|
Hepatitis C, Chronic | 1 | 2010 | 1031 | 0.050 |
Why?
|
Choline Deficiency | 2 | 2010 | 28 | 0.050 |
Why?
|
Mice, Obese | 2 | 2010 | 425 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3799 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2010 | 2214 | 0.040 |
Why?
|
Prospective Studies | 2 | 2021 | 53291 | 0.040 |
Why?
|
Methionine | 2 | 2010 | 590 | 0.040 |
Why?
|
Bile Ducts | 2 | 2009 | 284 | 0.040 |
Why?
|
Humans | 11 | 2023 | 744376 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2008 | 3486 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2010 | 4253 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2010 | 19233 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2009 | 10484 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3873 | 0.030 |
Why?
|
Athletes | 1 | 2021 | 1093 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2023 | 2269 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4751 | 0.030 |
Why?
|
Blotting, Western | 2 | 2010 | 5181 | 0.030 |
Why?
|
Male | 7 | 2022 | 350118 | 0.030 |
Why?
|
Aged | 3 | 2022 | 163284 | 0.030 |
Why?
|
Risk Factors | 1 | 2019 | 72295 | 0.030 |
Why?
|
Adult | 3 | 2021 | 214056 | 0.030 |
Why?
|
Veratrum Alkaloids | 1 | 2010 | 25 | 0.020 |
Why?
|
Obesity | 2 | 2010 | 12745 | 0.020 |
Why?
|
Hepatitis Viruses | 1 | 2010 | 17 | 0.020 |
Why?
|
Liver | 3 | 2012 | 7475 | 0.020 |
Why?
|
Rats, Zucker | 1 | 2010 | 128 | 0.020 |
Why?
|
Genetic Testing | 1 | 2023 | 3444 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2010 | 361 | 0.020 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 175 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 2010 | 8300 | 0.020 |
Why?
|
Hybridomas | 1 | 2009 | 452 | 0.020 |
Why?
|
Ligation | 1 | 2008 | 453 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2008 | 251 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2010 | 21833 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6442 | 0.020 |
Why?
|
Mesoderm | 1 | 2010 | 686 | 0.020 |
Why?
|
Caspase 3 | 1 | 2009 | 758 | 0.020 |
Why?
|
Interleukin-13 | 1 | 2009 | 389 | 0.020 |
Why?
|
Mice | 5 | 2012 | 81202 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2009 | 1828 | 0.020 |
Why?
|
Hypertension, Portal | 1 | 2008 | 220 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1865 | 0.020 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2008 | 625 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2009 | 1147 | 0.020 |
Why?
|
Female | 3 | 2022 | 380200 | 0.020 |
Why?
|
Cell Line | 2 | 2010 | 16000 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2009 | 1369 | 0.020 |
Why?
|
Fibrosis | 1 | 2012 | 2029 | 0.020 |
Why?
|
Disease Progression | 2 | 2012 | 13285 | 0.020 |
Why?
|
Animals | 6 | 2012 | 168770 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2009 | 1200 | 0.010 |
Why?
|
Rats | 2 | 2010 | 24252 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2009 | 1359 | 0.010 |
Why?
|
Actins | 1 | 2009 | 2121 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 2504 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4222 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5524 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2009 | 3207 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2009 | 2866 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 40558 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5974 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2010 | 3690 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11366 | 0.010 |
Why?
|
Gene Expression | 1 | 2008 | 7798 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 13035 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 16692 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 77459 | 0.010 |
Why?
|
Middle Aged | 2 | 2022 | 213388 | 0.010 |
Why?
|
Apoptosis | 1 | 2009 | 9726 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2010 | 11486 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 16367 | 0.010 |
Why?
|
Diet | 1 | 2010 | 7937 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18034 | 0.010 |
Why?
|